Generate a tailored SOP for Dr. Roger Chung. Improve your application with a focused, well-structured draft.
Professor Roger Chung is a recognized expert in Neurobiology and Neurochemistry, serving as the Pro Vice-Chancellor for Academic Health Strategy at Macquarie University. His academic journey began with a PhD in Molecular Biology completed in 2003. Chung has held significant research roles at the University of Tasmania and Macquarie University, where he co-led the establishment of the Centre for Motor Neuron Disease Research in 2013. His research aims to elucidate the biochemical and molecular mechanisms associated with neurodegenerative diseases, particularly focusing on Motor Neuron Disease (MND) and its connection to mutations leading to the aggregation of proteins. A notable highlight of his work includes the development of gene therapies for MND/ALS, utilizing innovative synthetic biology techniques to create molecular switches for controlling therapeutic gene expression. Recently, he co-founded Celosia Therapeutics, aiming to advance gene therapy advancements. Chung is passionate about mentoring new researchers and is currently seeking individuals skilled in molecular biology and computational biology to join his research program. His extensive research has fostered numerous collaborations and projects aimed at unraveling the complexities of neurodegeneration and protein aggregation in MND.
Macquarie University • Sydney, Australia
Oversees the academic health strategy and research initiatives at the university.
Faculty of Medicine, Health & Human Sciences, Macquarie University • Sydney, Australia
Leads research efforts and innovation within the faculty.
Applied to Department of Business (MBA Program).